|Awarded On||February 21, 2018|
|Title||EXTernal beam radiation to Eliminate Nominal metastatic Disease (EXTEND): A randomized phase II basket trial to assess local control of oligometastatic disease|
|Award Mechanism||Individual Investigator Research Awards for Clinical Translation|
|Institution/Organization||The University of Texas M.D. Anderson Cancer Center|
|Principal Investigator/Program Director||Chad Tang|
|Cancer Sites||All Sites|
Cancers that have spread to organs away from their original location are labelled as “metastatic” and have generally been considered universally fatal. A diagnosis of metastatic cancer usually means treatment that is conservative, palliating symptoms and/or extending life moderately, but not curing patients. This paradigm was originally developed in the early days of cancer treatment and has generally changed little. However, with improvements in our ability to treat and diagnose, we are starting to understand that not all metastatic cancers should be considered equal. That some patients with metastatic cancer have disease spread only to a few additional organs. We have begun labeling those ...